Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System.

Kinoshita M, Higashihara E, Kawano H, Higashiyama R, Koga D, Fukui T, Gondo N, Oka T, Kawahara K, Rigo K, Hague T, Katsuragi K, Sudo K, Takeshi M, Horie S, Nutahara K.

PLoS One. 2016 Nov 11;11(11):e0166288. doi: 10.1371/journal.pone.0166288. eCollection 2016.

2.

Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples.

Yin Y, Lan JH, Nguyen D, Valenzuela N, Takemura P, Bolon YT, Springer B, Saito K, Zheng Y, Hague T, Pasztor A, Horvath G, Rigo K, Reed EF, Zhang Q.

PLoS One. 2016 Oct 31;11(10):e0165810. doi: 10.1371/journal.pone.0165810. eCollection 2016.

3.

Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Mack SJ, Milius RP, Gifford BD, Sauter J, Hofmann J, Osoegawa K, Robinson J, Groeneweg M, Turenchalk GS, Adai A, Holcomb C, Rozemuller EH, Penning MT, Heuer ML, Wang C, Salit ML, Schmidt AH, Parham PR, Müller C, Hague T, Fischer G, Fernandez-Viňa M, Hollenbach JA, Norman PJ, Maiers M.

Hum Immunol. 2015 Dec;76(12):954-62. doi: 10.1016/j.humimm.2015.09.011. Epub 2015 Sep 25.

4.

HLA typing from 1000 genomes whole genome and whole exome illumina data.

Major E, Rigó K, Hague T, Bérces A, Juhos S.

PLoS One. 2013 Nov 6;8(11):e78410. doi: 10.1371/journal.pone.0078410. eCollection 2013.

5.

Headache sufferers' drawings reflect distress, disability and illness perceptions.

Broadbent E, Niederhoffer K, Hague T, Corter A, Reynolds L.

J Psychosom Res. 2009 May;66(5):465-70. doi: 10.1016/j.jpsychores.2008.09.006. Epub 2009 Mar 3.

PMID:
19379963
6.

Determination of metal ion content of beverages and estimation of target hazard quotients: a comparative study.

Hague T, Petroczi A, Andrews PL, Barker J, Naughton DP.

Chem Cent J. 2008 Jun 25;2:13. doi: 10.1186/1752-153X-2-13.

7.

Reduction of paraquat-induced renal cytotoxicity by manganese and copper complexes of EGTA and EHPG.

Samai M, Hague T, Naughton DP, Gard PR, Chatterjee PK.

Free Radic Biol Med. 2008 Feb 15;44(4):711-21. Epub 2007 Nov 13.

PMID:
18067869
8.

Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases.

Hague T, Andrews PL, Barker J, Naughton DP.

Behav Pharmacol. 2006 Sep;17(5-6):425-30.

PMID:
16940763
9.

Catalytic superoxide scavenging by metal complexes of the calcium chelator EGTA and contrast agent EHPG.

Fisher AE, Hague TA, Clarke CL, Naughton DP.

Biochem Biophys Res Commun. 2004 Oct 8;323(1):163-7.

PMID:
15351716

Supplemental Content

Support Center